» Articles » PMID: 37179416

Modulating AHR Function Offers Exciting Therapeutic Potential in Gut Immunity and Inflammation

Overview
Journal Cell Biosci
Publisher Biomed Central
Specialty Biology
Date 2023 May 13
PMID 37179416
Authors
Affiliations
Soon will be listed here.
Abstract

Aryl hydrocarbon receptor (AHR) is a ligand-dependent transcription factor. 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) is a classical exogenous synthetic ligand of AHR that has significant immunotoxic effects. Activation of AHR has beneficial effects on intestinal immune responses, but inactivation or overactivation of AHR can lead to intestinal immune dysregulation and even intestinal diseases. Sustained potent activation of AHR by TCDD results in impairment of the intestinal epithelial barrier. However, currently, AHR research has been more focused on elucidating physiologic AHR function than on dioxin toxicity. The appropriate level of AHR activation plays a role in maintaining gut health and protecting against intestinal inflammation. Therefore, AHR offers a crucial target to modulate intestinal immunity and inflammation. Herein, we summarize our current understanding of the relationship between AHR and intestinal immunity, the ways in which AHR affects intestinal immunity and inflammation, the effects of AHR activity on intestinal immunity and inflammation, and the effect of dietary habits on intestinal health through AHR. Finally, we discuss the therapeutic role of AHR in maintaining gut homeostasis and relieving inflammation.

Citing Articles

The role of short-chain fatty acid in metabolic syndrome and its complications: focusing on immunity and inflammation.

Yu W, Sun S, Fu Q Front Immunol. 2025; 16:1519925.

PMID: 39991152 PMC: 11842938. DOI: 10.3389/fimmu.2025.1519925.


Profiling Genome-Wide Methylation Patterns in Cattle Infected with .

Boschiero C, Beshah E, Zhu X, Tuo W, Liu G Int J Mol Sci. 2025; 26(1.

PMID: 39795948 PMC: 11719486. DOI: 10.3390/ijms26010089.


The formidable guardian: Type 3 immunity in the intestine of pigs.

Yang Z, Zhang D, Jiang Z, Peng J, Wei H Virulence. 2024; 15(1):2424325.

PMID: 39497434 PMC: 11552283. DOI: 10.1080/21505594.2024.2424325.


The influence of AHR on immune and tissue biology.

Stockinger B, Diaz O, Wincent E EMBO Mol Med. 2024; 16(10):2290-2298.

PMID: 39242971 PMC: 11473696. DOI: 10.1038/s44321-024-00135-w.


Aryl hydrocarbon receptor: current perspectives on key signaling partners and immunoregulatory role in inflammatory diseases.

Bahman F, Choudhry K, Al-Rashed F, Al-Mulla F, Sindhu S, Ahmad R Front Immunol. 2024; 15:1421346.

PMID: 39211042 PMC: 11358079. DOI: 10.3389/fimmu.2024.1421346.


References
1.
Bradshaw T, Bell D . Relevance of the aryl hydrocarbon receptor (AhR) for clinical toxicology. Clin Toxicol (Phila). 2009; 47(7):632-42. DOI: 10.1080/15563650903140423. View

2.
Yi T, Wang J, Zhu K, Tang Y, Huang S, Shui X . Aryl Hydrocarbon Receptor: A New Player of Pathogenesis and Therapy in Cardiovascular Diseases. Biomed Res Int. 2018; 2018:6058784. PMC: 6015699. DOI: 10.1155/2018/6058784. View

3.
Kress S, Reichert J, Schwarz M . Functional analysis of the human cytochrome P4501A1 (CYP1A1) gene enhancer. Eur J Biochem. 1999; 258(2):803-12. DOI: 10.1046/j.1432-1327.1998.2580803.x. View

4.
Kiyomatsu-Oda M, Uchi H, Morino-Koga S, Furue M . Protective role of 6-formylindolo[3,2-b]carbazole (FICZ), an endogenous ligand for arylhydrocarbon receptor, in chronic mite-induced dermatitis. J Dermatol Sci. 2018; 90(3):284-294. DOI: 10.1016/j.jdermsci.2018.02.014. View

5.
Park R, Madhavaram S, Ji J . The Role of Aryl-Hydrocarbon Receptor (AhR) in Osteoclast Differentiation and Function. Cells. 2020; 9(10). PMC: 7602422. DOI: 10.3390/cells9102294. View